![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA to Streamline Antibiotic Development; Combat Resistance
FDA to Streamline Antibiotic Development; Combat Resistance
July 26, 2013
The FDA is proposing four drug development approaches that it hopes will help streamline and incentivize development of drugs for patients with antibacterial drug-resistant infections. The guidance, released in Q&A format, could be a game-changer in the agency’s war against drug-resistant bacterial diseases and perk drugmaker interest in investing more in antibacterial research.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
21Oct